Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 7Observational 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 109Neoplasms 108Lung Neoplasms 66Prostatic Neoplasms 57Colorectal Neoplasms 48Carcinoma, Non-Small-Cell Lung 44Pancreatic Neoplasms 31Hematologic Neoplasms 28Multiple Myeloma 23Leukemia, Myeloid, Acute 23Stomach Neoplasms 21Ovarian Neoplasms 21Carcinoma, Hepatocellular 21Brain Neoplasms 21Lymphoma 20Melanoma 19Esophageal Neoplasms 19Precursor Cell Lymphoblastic Leukemia-Lymphoma 18Disease 18Urinary Bladder Neoplasms 17Colonic Neoplasms 16Uterine Cervical Neoplasms 15Liver Neoplasms 15Leukemia, Lymphocytic, Chronic, B-Cell 15Head and Neck Neoplasms 14Endometrial Neoplasms 14Lymphoma, Non-Hodgkin 13Leukemia 13Kidney Neoplasms 13Carcinoma, Renal Cell 13

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Breast Carcinoma In Situ × 30 days × Clear all
NCT06401889 2026-05-19

Enhancing Skin Appearance and Quality of Life in Breast Cancer Survivors on Aromatase Inhibitor Therapy

Mayo Clinic

Recruiting
35 enrolled
Breast

Breast Carcinoma In Situ

Data powered by HemOnc (CC BY 4.0) Colophon âš¡